{"id":16089,"date":"2016-09-27T12:10:21","date_gmt":"2016-09-27T10:10:21","guid":{"rendered":"http:\/\/mabdesign.fr\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/"},"modified":"2016-09-27T12:10:21","modified_gmt":"2016-09-27T10:10:21","slug":"biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/","title":{"rendered":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"http:\/\/www.biocellchallenge.com\/\" target=\"_blank\" rel=\"noopener\"><strong>BioCellChallenge SAS<\/strong><\/a>, sp\u00e9cialis\u00e9e dans la conception et le d\u00e9veloppement de syst\u00e8mes d\u2019internalisation de biomol\u00e9cules dans les cellules vivantes, pr\u00e9sente aujourd\u2019hui les r\u00e9sultats de l\u2019\u00e9tude portant sur l\u2019efficacit\u00e9 <em>in vivo<\/em> d\u2019un anticorps th\u00e9rapeutique de type ADC (Antibody Drug Conjugate) associ\u00e9 \u00e0 ImmunoCellin. Les r\u00e9sultats montrent que l\u2019efficacit\u00e9 d\u2019un anticorps th\u00e9rapeutique utilis\u00e9 pour traiter le cancer du sein peut \u00eatre multipli\u00e9e par sept en injection intraveineuse.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/us9.campaign-archive1.com\/?u=6601069e6acdb5a102b244827&amp;id=95771b4711\" target=\"_blank\" rel=\"noopener\">Lire le communiqu\u00e9 de presse<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse L\u2019activit\u00e9 anti-tumorale est multipli\u00e9e par sept quand l\u2019ADC est associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.<\/p>\n","protected":false},"author":1,"featured_media":8476,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,13],"tags":[],"class_list":["post-16089","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-nos-adherents"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse - MabDesign<\/title>\n<meta name=\"description\" content=\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse - MabDesign\" \/>\n<meta property=\"og:description\" content=\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-27T10:10:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse\",\"datePublished\":\"2016-09-27T10:10:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\"},\"wordCount\":106,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Nos adh\u00e9rents\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\",\"name\":\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg\",\"datePublished\":\"2016-09-27T10:10:21+00:00\",\"description\":\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg\",\"width\":400,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse - MabDesign","description":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/","og_locale":"en_US","og_type":"article","og_title":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse - MabDesign","og_description":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.","og_url":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/","og_site_name":"MabDesign","article_published_time":"2016-09-27T10:10:21+00:00","og_image":[{"width":400,"height":250,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg","type":"image\/jpeg"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse","datePublished":"2016-09-27T10:10:21+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/"},"wordCount":106,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg","articleSection":["Actualit\u00e9s","Nos adh\u00e9rents"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/","url":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/","name":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg","datePublished":"2016-09-27T10:10:21+00:00","description":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e associ\u00e9 \u00e0 la technologie d\u2019internalisation ImmunoCellin.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2023\/10\/LOGO_BCC.jpg","width":400,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/biocellchallenge-obtient-des-resultats-tres-prometteurs-pour-sa-premiere-etude-realisee-en-intraveineuse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"BioCellChallenge obtient des r\u00e9sultats tr\u00e8s prometteurs pour sa premi\u00e8re \u00e9tude r\u00e9alis\u00e9e en intraveineuse"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16089"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16089\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/8476"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}